11. Bormann KH, Stühmer C, Z’Graggen M, Kokemöller H, Rücker M, Gellrich NC. IL-1 polymorphism and periimplantitis. A literature review. Schweiz Monatsschr Zahnmed 2010;120:510–520.
12. Bornstein MM, Cionca N, Mombelli A. Systemic conditions and treatments as risks for implant therapy. Int J Oral Maxillofac Implants 2009;24(suppl):12–27.
13. Brand HS. Cardiovascular responses in patients and dentists during dental treatment. Int Dent J 1999;49: 60–66.
14. Busenlechner D, Fürhauser R, Haas R, Watzek G, Mailath G, Pommer B. Long-term implant success at the Academy for Oral Implantology: 8-year follow-up and risk factor analysis. J Periodontal Implant Sci 2014;44:102–108.
15. Carter LC. Paget’s disease: important features for the general practitioner. Compendium 1990;11:662, 664–665, 668–669.
16. Chadha GK, Ahmadieh A, Kumar S, Sedghizadeh PP. Osseointegration of dental implants and osteonecrosis of the jaw in patients treated with bisphosphonate therapy: a systematic review. J Oral Implantol 2013;39:510–520.
17. Chhabra N, Goswami M, Chhabra A. Genetic basis of dental agenesis – molecular genetics patterning clinical dentistry. Med Oral Patol Oral Cir Bucal 2014;19: e112–e119.
18. Chiapasco M, Zaniboni M, Rimondini L. Dental implants placed in grafted maxillary sinuses: a retrospective analysis of clinical outcome according to the initial clinical situation and a proposal of defect classification. Clin Oral Implants Res 2008;19:416–428.
19. Choukroun J, Khoury G, Khoury F, et al. Two neglected biologic risk factors in bone grafting and implantology: high low-density lipoprotein cholesterol and low serum vitamin D. J Oral Implantol 2014;40:110–114.
20. Degidi M, Piattelli A. Immediately loaded bar-connected implants with an anodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: a case report with a 12-month follow-up. Clin Implant Dent Relat Res 2003;5:269–272.
21. Deppe H, Betz W, Maager B et al. S2k-Leitlinie: Dentale digitale Volumentomografie. AWMF-Reg.-Nr. 083/005, 2013.
22. Erdogan Ö, Uçar Y, Tatlı U, Sert M, Benlidayı ME, Evlice B. A clinical prospective study on alveolar bone augmentation and dental implant success in patients with type 2 diabetes. Clin Oral Implants Res 2015;26: 1267–1275.
23. European Commission. Energy Protection Radiation No 172: Cone beam CT for dental and maxillofacial radiology (evidence-based guidelines), 2012.
24. Ewers R, Schicho K, Undt G, et al. Basic research and 12 years of clinical experience in computer-assisted navigation technology: a review. Int J Oral Maxillofac Surg 2005;34:1–8.
25. Famili P, Quigley S, Mosher T. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study. Compend Contin Educ Dent 2011;32:E106–E109.
26. Fu JH, Bashutski JD, Al-Hezaimi K, Wang HL. Statins, glucocorticoids, and nonsteroidal anti-inflammatory drugs: their influence on implant healing. Implant Dent 2012;21:362–367.
27. Ganz SD. Three-dimensional imaging and guided surgery for dental implants. Dent Clin North Am 2015;59: 265–290.
28. Gómez-Moreno G, Aguilar-Salvatierra A, Rubio Roldán J, Guardia J, Gargallo J, Calvo-Guirado JL. Peri-implant evaluation in type 2 diabetes mellitus patients: a 3-year study. Clin Oral Implants Res 2015;26:1031–1035.
29. Goodacre CJ, Bernal G, Rungcharassaeng K, Kan JY. Clinical complications with implants and implant prostheses. J Prosthet Dent 2003;90:121–132.
30. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008;13: 1227–1239.
31. Grötz KA, Piesold J-U, Al-Nawas B. S3-Leitlinie: Bisphosphonat-assoziierte Kiefernekrose (BP-ONJ) und andere Medikamenten-assoziierte Kiefernekrosen. AWMF-Register Nr. 007/091, 2012.
32. Gruica B, Wang HY, Lang NP, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004;15: 393–400.
33. Gulati M, Anand V, Salaria SK, Jain N, Gupta S. Computerized implant-dentistry: advances toward automation. J Indian Soc Periodontol 2015;19:5–10.
34. Hadji P, Felsenberg D, Amling M, Hofbauer LC, Kandenwein JA, Kurth A. The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis. Osteoporos Int 2014;25:339–347.
35. Hadji P, Klein S, Gothe H, et al. The epidemiology of osteoporosis – Bone Evaluation Study (BEST): an analysis of routine health insurance data. Dtsch Arztebl Int 2013;110:52–57.
36. Hadji P, Klein S, Häussler B, et al. The bone evaluation study (BEST): patient care and persistence to treatment of osteoporosis in Germany. Int J Clin Pharmacol Ther 2013;51:868–872.
37. Haessler D, Vizethum F, Zoller JE. Autogene Knochentransplantation mit Hilfe eines Spankollectors – eine Methodenbeschreibung. Implantologie 1995;4:315–322.
38. Hassfeld S, Mühling J, Zöller J. Intraoperative navigation in oral and maxillofacial surgery. Int J Oral Maxillofac Surg 1995;24(1 Pt 2):111–119.
39. Hounsfield GN. Computerized transverse axial scanning (tomography). 1. Description of system. Br J Radiol 1973;46:1016–1022.
40. Irlbeck T, Zwißler B, Bauer A. ASA-Klassifikation. Der Anaesthesist 2017;66:5–10.
41. James PD, Goodeve AC. von Willebrand disease. Genet Med 2011;13:365–376.
42. Jeffcoat MK. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21:349–353.
43. Jemt T, Lekholm U. Single implants and buccal bone grafts in the anterior maxilla: measurements of buccal crestal contours in a 6-year prospective clinical study. Clin Implant Dent Relat Res 2005;7:127–135.
44. Jivraj S, Corrado P, Chee W. An interdisciplinary approach to treatment planning in implant dentistry. Br Dent J 2007;202:11–17.
45. Jung RE, Al-Nawas B, Araujo M et al. Group 1 ITI consensus report: The influence of implant length and design and medications on clinical and patient-reported outcomes. Clin Oral Implants Res 2018; 29(suppl 16):69–77.
46. Kasat V, Ladda R. Smoking and dental implants. J Int Soc Prev Community Dent 2012;2:38–41.
47. Keats AS. The ASA classification of physical status – a recapitulation. Anesthesiology 1978;49:233–236.
48. Khan AA. Medical management of primary hyperparathyroidism. J Clin Densitom 2013;16:60–63.
49. Khoury F, Doliveux R. The bone core technique for the augmentation of limited bony defects: Five-year prospective study with a new minimally invasive technique. Int J Periodontics Restorative Dent 2018;38: 199–207.
50. Klein M, Hein A, Lueth T, Bier J. Robot-assisted placement of craniofacial implants. Int J Oral Maxillofac Implants 2003;18:712–718.
51. Kumar R, Carcao M. Inherited abnormalities of coagulation: hemophilia, von Willebrand disease, and beyond. Pediatr Clin North Am 2013;60:1419–1441.
52. Liddelow G, Klineberg I. Patient-related risk factors for implant therapy. A critique of pertinent literature. Aust Dent J 2011;56:417–426.
53. Lopes A, Maló P, de Araújo Nobre M, Sánchez-Fernández E, Gravito I. The NobelGuide ®All-on-4 ®treatment concept for rehabilitation of edentulous jaws: A retrospective report on the 7-years clinical and 5-years radiographic outcomes. Clin Implant Dent Relat Res 2017;19:233–244.
54. Michaeli E, Weinberg I, Nahlieli O. Dental implants in the diabetic patient: systemic and rehabilitative considerations. Quintessence Int 2009;40:639–645.
55. Miller RJ, Bier J. Surgical navigation in oral implantology. Implant Dent 2006;15:41–47.
56. Mischkowski RA, Scherer P, Ritter L, Neugebauer J, Keeve E, Zöller JE. Diagnostic quality of multiplanar reformations obtained with a newly developed cone beam device for maxillofacial imaging. Dentomaxillofac Radiol 2008;37:1–9.
Читать дальше